K. Miller

发表

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

Anthony Rhodes, Paul Valenstein, Keith Miller, 2010, Archives of pathology & laboratory medicine.

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version).

Anthony Rhodes, Paul Valenstein, Keith Miller, 2010, Archives of pathology & laboratory medicine.

Standardization of Positive Controls in Diagnostic Immunohistochemistry: Recommendations From the International Ad Hoc Expert Committee

Clive R. Taylor, B. Gilks, P. Swanson, 2015, Applied immunohistochemistry & molecular morphology : AIMM.

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1 Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry Biomarkers

Clive R. Taylor, Jacqueline A. Hall, A. Marchetti, 2017, Applied immunohistochemistry & molecular morphology : AIMM.

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

Anthony Rhodes, Paul Valenstein, Keith Miller, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 4 Tissue Tools for Quality Assurance in Immunohistochemistry

Clive R. Taylor, Jacqueline A. Hall, A. Marchetti, 2017, Applied immunohistochemistry & molecular morphology : AIMM.

Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification.

S. Knuutila, A. Scarpa, A. Sapino, 2015, American journal of cancer research.

‘Breast cancer biomarkers in clinical testing: analysis of a UK NEQAS ICC & ISH database containing results from 199 300 patients’

M. Dowsett, S. Pinder, J. Bartlett, 2020, The journal of pathology. Clinical research.

Breast cancer biomarkers in clinical testing: analysis of a UK national external quality assessment scheme for immunocytochemistry and in situ hybridisation database containing results from 199 300 patients

M. Dowsett, S. Pinder, J. Bartlett, 2018, The journal of pathology. Clinical research.

Variation in rates of oestrogen receptor positivity in breast cancer again

B. Jasani, K. Miller, A. Rhodes, 2002, BMJ : British Medical Journal.

The Use of the Immunohistochemical Biotin-Free Visualization Systems for Estrogen Receptor Evaluation of Breast Cancer

R. Rocha, H. Gobbi, F. Soares, 2009 .

A UK NEQAS ICC and ISH multicentre study using the Kreatech Poseidon HER2 FISH probe: intersite variation can be rigorously controlled using FISH

I. Ellis, J. Bartlett, F. Campbell, 2010, Histopathology.

An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer

John M S Bartlett, Liron Pantanowitz, Carsten Denkert, 2018, Modern Pathology.

FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma

A. Nottegar, G. Zamboni, G. Tortora, 2012, Journal of Experimental & Clinical Cancer Research.

ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment Regimen

P. Maxwell, K. Kerr, E. Thunnissen, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC Laboratories

Jacqueline A. Hall, A. Marchetti, M. Dietel, 2017, Applied immunohistochemistry & molecular morphology : AIMM.

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics.

Keith Miller, Clive R Taylor, Manfred Dietel, 2017, Applied immunohistochemistry & molecular morphology : AIMM.

The Relevance of External Quality Assessment for Molecular Testing for ALK Positive Non-Small Cell Lung Cancer: Results from Two Pilot Rounds Show Room for Optimization

L. Bubendorf, E. Schuuring, K. Kerr, 2014, PloS one.

Follicular Dendritic Cells in Reactive and Neoplastic Lymphoid Tissues: A Reevaluation of Staining Patterns of CD21, CD23, and CD35 Antibodies in Paraffin Sections After Wet Heat-Induced Epitope Retrieval

P. Isaacson, K. Miller, T. Krenács, 2001, Applied immunohistochemistry & molecular morphology : AIMM.

A UK NEQAS ring study evaluating observer variation in the diagnosis of HER2 amplification using the Kreatech™ HER2 FISH probe.

I. Ellis, A. O'Grady, E. Kay, 2009 .

Audit of breast biomarkers markers, HER2.ER & PR in the UK: an update by the UK National External Quality Assessment Scheme for Immunocytochemistry and In Situ Hybridisation (UK NEQAS ICC & ISH)

S. Parry, K. Miller, M. Ibrahim, 2011 .

Nondestructive Quality Control of HER2 Control Cell Line Sections: The use of Interferometry for Measuring Section Thickness and Implications for HER2 Interpretation on Breast Tissue

K. Miller, M. Ibrahim, C. Barker, 2009, Applied immunohistochemistry & molecular morphology : AIMM.

Immunohistochemical detection of steroid receptors in breast cancer: a working protocol

D Barnes, T Anderson, S. Pinder, 2000, Journal of clinical pathology.

Breast Cancer Biomarkers

J. Bartlett, B. Jasani, K. Miller, 2011 .

Nondestructive Quality Control of HER 2 Control Cell Line Sections

K. Miller, M. Ibrahim, C. Barker, 2009 .

Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer-Clinical Notice

Anthony Rhodes, Paul Valenstein, Daniel F. Hayes, 2010 .

Interpretation of Immunohistochemical Analysis of MisMatch Repair (MMR) Protein Expression in Tissue Sections for Investigation of Suspected Lynch / Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Syndrome

L. Happerfield, M. Arends, I. Frayling, 2008 .

Colorectal Cancer Stratification in the Routine Clinical Pathway: A District General Hospital Experience

C. D'Arrigo, Jenny C. Taylor, I. Frayling, 2019, Applied immunohistochemistry & molecular morphology : AIMM.

Risk of recurrence estimates with IHC4+C are tolerant of variations in staining and scoring: an analytical validity study

M. Dowsett, L. Zabaglo, I. Smith, 2015, Journal of Clinical Pathology.

Standard Reference Material: Cell Line Development and Use of Reference Cell Lines as Standards for External Quality Assurance of Her2 IHC and ISH Testing

Michael Morgan, John M. S. Bartlett, Jeremy Walker, 2010 .

Abstract P3-10-21: Audit of the Accuracy of Immunohistochemical (IHC) Testing of HER2 Status of Breast Cancer in the United Kingdom: An Interim Analysis

B. Jasani, K. Miller, M. Ibrahim, 2010 .

Staining performance of ALK and ROS1 immunohistochemistry and influence on interpretation in Non-Small-Cell Lung Cancer.

E. Schuuring, E. Thunnissen, P. Pauwels, 2020, The Journal of molecular diagnostics : JMD.

Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries

B. Jasani, K. Miller, A. Rhodes, 2000, Journal of clinical pathology.

American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

M. Dowsett, D. Visscher, M. Hammond, 2010, Journal of oncology practice.

Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening

D. Barnes, B. Jasani, K. Miller, 2000, Journal of clinical pathology.

Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of unreliable assays.

L. Bobrow, D. Barnes, B. Jasani, 2001, American journal of clinical pathology.

HER2 testing in the UK: further update to recommendations

I. Ellis, M. Dowsett, S. Pinder, 2008, Journal of Clinical Pathology.

American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

M. Dowsett, L. McShane, D. Allred, 2010, Journal of oncology practice.